Advertisement

Index by author

September 01, 1991; Volume 40,Issue 3

A

  1. Anderson, R

    1. Auranofin inactivates phosphofructokinase in human neutrophils, leading to depletion of intracellular ATP and inhibition of superoxide generation and locomotion.
      R Anderson, C E Van Rensburg, G K Jooné and A Lessing
      Molecular Pharmacology September 1991, 40 (3) 427-434;

  2. Arena, J P

    1. Avermectin-sensitive chloride currents induced by Caenorhabditis elegans RNA in Xenopus oocytes.
      J P Arena, K K Liu, P S Paress and D F Cully
      Molecular Pharmacology September 1991, 40 (3) 368-374;

B

  1. Balla, T

    1. Angiotensin II receptor subtypes and biological responses in the adrenal cortex and medulla.
      T Balla, A J Baukal, S Eng and K J Catt
      Molecular Pharmacology September 1991, 40 (3) 401-406;

  2. Baukal, A J

    1. Angiotensin II receptor subtypes and biological responses in the adrenal cortex and medulla.
      T Balla, A J Baukal, S Eng and K J Catt
      Molecular Pharmacology September 1991, 40 (3) 401-406;

  3. Begleiter, A

    1. Mechanisms for the modulation of alkylating activity by the quinone group in quinone alkylating agents.
      A Begleiter, M K Leith and S S Pan
      Molecular Pharmacology September 1991, 40 (3) 454-458;

  4. Bisacchi, G S

    1. Selective activity and cellular pharmacology of (1R-1 alpha,2 beta,3 alpha)-9-[2,3-bis(hydroxymethyl)cyclobutyl]guanine in herpesvirus-infected cells.
      G Yamanaka, A V Tuomari, M Hagen, B McGeever-Rubin, B Terry, M Haffey, G S Bisacchi and A K Field
      Molecular Pharmacology September 1991, 40 (3) 446-453;

  5. Bridson, P K

    1. Microsomal reduction of 3-amino-1,2,4-benzotriazine 1,4-dioxide to a free radical.
      R V Lloyd, D R Duling, G V Rumyantseva, R P Mason and P K Bridson
      Molecular Pharmacology September 1991, 40 (3) 440-445;

  6. Bürgin, M

    1. Halothane metabolism: immunochemical evidence for molecular mimicry of trifluoroacetylated liver protein adducts by constitutive polypeptides.
      U Christen, M Bürgin and J Gut
      Molecular Pharmacology September 1991, 40 (3) 390-400;

C

  1. Camus, J

    1. Binding kinetics of quinuclidinyl benzilate and methyl-quinuclidinyl benzilate enantiomers at neuronal (M1), cardiac (M2), and pancreatic (M3) muscarinic receptors.
      M Waelbroeck, M Tastenoy, J Camus and J Christophe
      Molecular Pharmacology September 1991, 40 (3) 413-420;

  2. Catt, K J

    1. Angiotensin II receptor subtypes and biological responses in the adrenal cortex and medulla.
      T Balla, A J Baukal, S Eng and K J Catt
      Molecular Pharmacology September 1991, 40 (3) 401-406;

  3. Christen, U

    1. Halothane metabolism: immunochemical evidence for molecular mimicry of trifluoroacetylated liver protein adducts by constitutive polypeptides.
      U Christen, M Bürgin and J Gut
      Molecular Pharmacology September 1991, 40 (3) 390-400;

  4. Christophe, J

    1. Binding kinetics of quinuclidinyl benzilate and methyl-quinuclidinyl benzilate enantiomers at neuronal (M1), cardiac (M2), and pancreatic (M3) muscarinic receptors.
      M Waelbroeck, M Tastenoy, J Camus and J Christophe
      Molecular Pharmacology September 1991, 40 (3) 413-420;

  5. Cully, D F

    1. Avermectin-sensitive chloride currents induced by Caenorhabditis elegans RNA in Xenopus oocytes.
      J P Arena, K K Liu, P S Paress and D F Cully
      Molecular Pharmacology September 1991, 40 (3) 368-374;

D

  1. D'Angelo, D D

    1. Pharmacological characterization of rat alpha 2-adrenergic receptors.
      J K Harrison, D D D'Angelo, D W Zeng and K R Lynch
      Molecular Pharmacology September 1991, 40 (3) 407-412;

  2. Dudley, D T

    1. Characterization of angiotensin II (AT2) binding sites in R3T3 cells.
      D T Dudley, S E Hubbell and R M Summerfelt
      Molecular Pharmacology September 1991, 40 (3) 360-367;

  3. Duling, D R

    1. Microsomal reduction of 3-amino-1,2,4-benzotriazine 1,4-dioxide to a free radical.
      R V Lloyd, D R Duling, G V Rumyantseva, R P Mason and P K Bridson
      Molecular Pharmacology September 1991, 40 (3) 440-445;

E

  1. Eng, S

    1. Angiotensin II receptor subtypes and biological responses in the adrenal cortex and medulla.
      T Balla, A J Baukal, S Eng and K J Catt
      Molecular Pharmacology September 1991, 40 (3) 401-406;

F

  1. Farb, D H

    1. Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-D-aspartate receptor.
      F S Wu, T T Gibbs and D H Farb
      Molecular Pharmacology September 1991, 40 (3) 333-336;

  2. Field, A K

    1. Selective activity and cellular pharmacology of (1R-1 alpha,2 beta,3 alpha)-9-[2,3-bis(hydroxymethyl)cyclobutyl]guanine in herpesvirus-infected cells.
      G Yamanaka, A V Tuomari, M Hagen, B McGeever-Rubin, B Terry, M Haffey, G S Bisacchi and A K Field
      Molecular Pharmacology September 1991, 40 (3) 446-453;

  3. Furuya, H

    1. Polymerase chain reaction-directed identification, cloning, and quantification of human CYP2C18 mRNA.
      H Furuya, U A Meyer, H V Gelboin and F J Gonzalez
      Molecular Pharmacology September 1991, 40 (3) 375-382;

G

  1. Gelboin, H V

    1. Polymerase chain reaction-directed identification, cloning, and quantification of human CYP2C18 mRNA.
      H Furuya, U A Meyer, H V Gelboin and F J Gonzalez
      Molecular Pharmacology September 1991, 40 (3) 375-382;

  2. Gergeĺ, D

    1. Spin-trapping and antioxidant properties of illuminated and nonilluminated nifedipine and nimodipine in heart homogenate and model system.
      V Misík, A Stasko, D Gergeĺ and K Ondrias
      Molecular Pharmacology September 1991, 40 (3) 435-439;

  3. Gibbs, T T

    1. Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-D-aspartate receptor.
      F S Wu, T T Gibbs and D H Farb
      Molecular Pharmacology September 1991, 40 (3) 333-336;

  4. Glasel, J A

    1. Stereospecificity of opiate receptors in a synchronized culture of NG108-15 cells probed with fluorescent anti-idiotypic antibodies.
      M Ornatowska and J A Glasel
      Molecular Pharmacology September 1991, 40 (3) 354-359;

  5. Gonzalez, F J

    1. Polymerase chain reaction-directed identification, cloning, and quantification of human CYP2C18 mRNA.
      H Furuya, U A Meyer, H V Gelboin and F J Gonzalez
      Molecular Pharmacology September 1991, 40 (3) 375-382;

  6. Gut, J

    1. Halothane metabolism: immunochemical evidence for molecular mimicry of trifluoroacetylated liver protein adducts by constitutive polypeptides.
      U Christen, M Bürgin and J Gut
      Molecular Pharmacology September 1991, 40 (3) 390-400;

H

  1. Haffey, M

    1. Selective activity and cellular pharmacology of (1R-1 alpha,2 beta,3 alpha)-9-[2,3-bis(hydroxymethyl)cyclobutyl]guanine in herpesvirus-infected cells.
      G Yamanaka, A V Tuomari, M Hagen, B McGeever-Rubin, B Terry, M Haffey, G S Bisacchi and A K Field
      Molecular Pharmacology September 1991, 40 (3) 446-453;

  2. Hagen, M

    1. Selective activity and cellular pharmacology of (1R-1 alpha,2 beta,3 alpha)-9-[2,3-bis(hydroxymethyl)cyclobutyl]guanine in herpesvirus-infected cells.
      G Yamanaka, A V Tuomari, M Hagen, B McGeever-Rubin, B Terry, M Haffey, G S Bisacchi and A K Field
      Molecular Pharmacology September 1991, 40 (3) 446-453;

  3. Harrison, J K

    1. Pharmacological characterization of rat alpha 2-adrenergic receptors.
      J K Harrison, D D D'Angelo, D W Zeng and K R Lynch
      Molecular Pharmacology September 1991, 40 (3) 407-412;

  4. Hellwig, B

    1. Differentiation of erythrocyte-(GLUT1), liver-(GLUT2), and adipocyte-type (GLUT4) glucose transporters by binding of the inhibitory ligands cytochalasin B, forskolin, dipyridamole, and isobutylmethylxanthine.
      B Hellwig and H G Joost
      Molecular Pharmacology September 1991, 40 (3) 383-389;

  5. Hubbell, S E

    1. Characterization of angiotensin II (AT2) binding sites in R3T3 cells.
      D T Dudley, S E Hubbell and R M Summerfelt
      Molecular Pharmacology September 1991, 40 (3) 360-367;

J

  1. Jooné, G K

    1. Auranofin inactivates phosphofructokinase in human neutrophils, leading to depletion of intracellular ATP and inhibition of superoxide generation and locomotion.
      R Anderson, C E Van Rensburg, G K Jooné and A Lessing
      Molecular Pharmacology September 1991, 40 (3) 427-434;

  2. Joost, H G

    1. Differentiation of erythrocyte-(GLUT1), liver-(GLUT2), and adipocyte-type (GLUT4) glucose transporters by binding of the inhibitory ligands cytochalasin B, forskolin, dipyridamole, and isobutylmethylxanthine.
      B Hellwig and H G Joost
      Molecular Pharmacology September 1991, 40 (3) 383-389;

K

  1. Khodorov, B

    1. Desensitization of N-methyl-D-aspartate receptors in neurons dissociated from adult rat hippocampus.
      Y Zilberter, V Uteshev, S Sokolova and B Khodorov
      Molecular Pharmacology September 1991, 40 (3) 337-341;

L

  1. Leith, M K

    1. Mechanisms for the modulation of alkylating activity by the quinone group in quinone alkylating agents.
      A Begleiter, M K Leith and S S Pan
      Molecular Pharmacology September 1991, 40 (3) 454-458;

  2. Lessing, A

    1. Auranofin inactivates phosphofructokinase in human neutrophils, leading to depletion of intracellular ATP and inhibition of superoxide generation and locomotion.
      R Anderson, C E Van Rensburg, G K Jooné and A Lessing
      Molecular Pharmacology September 1991, 40 (3) 427-434;

  3. Liu, K K

    1. Avermectin-sensitive chloride currents induced by Caenorhabditis elegans RNA in Xenopus oocytes.
      J P Arena, K K Liu, P S Paress and D F Cully
      Molecular Pharmacology September 1991, 40 (3) 368-374;

  4. Lloyd, R V

    1. Microsomal reduction of 3-amino-1,2,4-benzotriazine 1,4-dioxide to a free radical.
      R V Lloyd, D R Duling, G V Rumyantseva, R P Mason and P K Bridson
      Molecular Pharmacology September 1991, 40 (3) 440-445;

  5. Luthin, G R

    1. Tissue-dependent association of muscarinic acetylcholine receptors with guanine nucleotide-binding regulatory proteins.
      D F Matesic, D R Manning and G R Luthin
      Molecular Pharmacology September 1991, 40 (3) 347-353;

  6. Lynch, K R

    1. Pharmacological characterization of rat alpha 2-adrenergic receptors.
      J K Harrison, D D D'Angelo, D W Zeng and K R Lynch
      Molecular Pharmacology September 1991, 40 (3) 407-412;

M

  1. Manning, D R

    1. Tissue-dependent association of muscarinic acetylcholine receptors with guanine nucleotide-binding regulatory proteins.
      D F Matesic, D R Manning and G R Luthin
      Molecular Pharmacology September 1991, 40 (3) 347-353;

  2. Mason, R P

    1. Microsomal reduction of 3-amino-1,2,4-benzotriazine 1,4-dioxide to a free radical.
      R V Lloyd, D R Duling, G V Rumyantseva, R P Mason and P K Bridson
      Molecular Pharmacology September 1991, 40 (3) 440-445;

  3. Matesic, D F

    1. Tissue-dependent association of muscarinic acetylcholine receptors with guanine nucleotide-binding regulatory proteins.
      D F Matesic, D R Manning and G R Luthin
      Molecular Pharmacology September 1991, 40 (3) 347-353;

  4. McGeever-Rubin, B

    1. Selective activity and cellular pharmacology of (1R-1 alpha,2 beta,3 alpha)-9-[2,3-bis(hydroxymethyl)cyclobutyl]guanine in herpesvirus-infected cells.
      G Yamanaka, A V Tuomari, M Hagen, B McGeever-Rubin, B Terry, M Haffey, G S Bisacchi and A K Field
      Molecular Pharmacology September 1991, 40 (3) 446-453;

  5. Meyer, U A

    1. Polymerase chain reaction-directed identification, cloning, and quantification of human CYP2C18 mRNA.
      H Furuya, U A Meyer, H V Gelboin and F J Gonzalez
      Molecular Pharmacology September 1991, 40 (3) 375-382;

  6. Misík, V

    1. Spin-trapping and antioxidant properties of illuminated and nonilluminated nifedipine and nimodipine in heart homogenate and model system.
      V Misík, A Stasko, D Gergeĺ and K Ondrias
      Molecular Pharmacology September 1991, 40 (3) 435-439;

O

  1. Ondrias, K

    1. Spin-trapping and antioxidant properties of illuminated and nonilluminated nifedipine and nimodipine in heart homogenate and model system.
      V Misík, A Stasko, D Gergeĺ and K Ondrias
      Molecular Pharmacology September 1991, 40 (3) 435-439;

  2. Ornatowska, M

    1. Stereospecificity of opiate receptors in a synchronized culture of NG108-15 cells probed with fluorescent anti-idiotypic antibodies.
      M Ornatowska and J A Glasel
      Molecular Pharmacology September 1991, 40 (3) 354-359;

P

  1. Pan, S S

    1. Mechanisms for the modulation of alkylating activity by the quinone group in quinone alkylating agents.
      A Begleiter, M K Leith and S S Pan
      Molecular Pharmacology September 1991, 40 (3) 454-458;

  2. Paress, P S

    1. Avermectin-sensitive chloride currents induced by Caenorhabditis elegans RNA in Xenopus oocytes.
      J P Arena, K K Liu, P S Paress and D F Cully
      Molecular Pharmacology September 1991, 40 (3) 368-374;

R

  1. Rudnick, G

    1. Binding of the cocaine analog 2 beta-[3H] carboxymethoxy-3 beta-(4-fluorophenyl)tropane to the serotonin transporter.
      G Rudnick and S C Wall
      Molecular Pharmacology September 1991, 40 (3) 421-426;

  2. Rumyantseva, G V

    1. Microsomal reduction of 3-amino-1,2,4-benzotriazine 1,4-dioxide to a free radical.
      R V Lloyd, D R Duling, G V Rumyantseva, R P Mason and P K Bridson
      Molecular Pharmacology September 1991, 40 (3) 440-445;

S

  1. Sokolova, S

    1. Desensitization of N-methyl-D-aspartate receptors in neurons dissociated from adult rat hippocampus.
      Y Zilberter, V Uteshev, S Sokolova and B Khodorov
      Molecular Pharmacology September 1991, 40 (3) 337-341;

  2. Stasko, A

    1. Spin-trapping and antioxidant properties of illuminated and nonilluminated nifedipine and nimodipine in heart homogenate and model system.
      V Misík, A Stasko, D Gergeĺ and K Ondrias
      Molecular Pharmacology September 1991, 40 (3) 435-439;

  3. Summerfelt, R M

    1. Characterization of angiotensin II (AT2) binding sites in R3T3 cells.
      D T Dudley, S E Hubbell and R M Summerfelt
      Molecular Pharmacology September 1991, 40 (3) 360-367;

T

  1. Tastenoy, M

    1. Binding kinetics of quinuclidinyl benzilate and methyl-quinuclidinyl benzilate enantiomers at neuronal (M1), cardiac (M2), and pancreatic (M3) muscarinic receptors.
      M Waelbroeck, M Tastenoy, J Camus and J Christophe
      Molecular Pharmacology September 1991, 40 (3) 413-420;

  2. Terry, B

    1. Selective activity and cellular pharmacology of (1R-1 alpha,2 beta,3 alpha)-9-[2,3-bis(hydroxymethyl)cyclobutyl]guanine in herpesvirus-infected cells.
      G Yamanaka, A V Tuomari, M Hagen, B McGeever-Rubin, B Terry, M Haffey, G S Bisacchi and A K Field
      Molecular Pharmacology September 1991, 40 (3) 446-453;

  3. Tuomari, A V

    1. Selective activity and cellular pharmacology of (1R-1 alpha,2 beta,3 alpha)-9-[2,3-bis(hydroxymethyl)cyclobutyl]guanine in herpesvirus-infected cells.
      G Yamanaka, A V Tuomari, M Hagen, B McGeever-Rubin, B Terry, M Haffey, G S Bisacchi and A K Field
      Molecular Pharmacology September 1991, 40 (3) 446-453;

U

  1. Uteshev, V

    1. Desensitization of N-methyl-D-aspartate receptors in neurons dissociated from adult rat hippocampus.
      Y Zilberter, V Uteshev, S Sokolova and B Khodorov
      Molecular Pharmacology September 1991, 40 (3) 337-341;

V

  1. Van Rensburg, C E

    1. Auranofin inactivates phosphofructokinase in human neutrophils, leading to depletion of intracellular ATP and inhibition of superoxide generation and locomotion.
      R Anderson, C E Van Rensburg, G K Jooné and A Lessing
      Molecular Pharmacology September 1991, 40 (3) 427-434;

W

  1. Waelbroeck, M

    1. Binding kinetics of quinuclidinyl benzilate and methyl-quinuclidinyl benzilate enantiomers at neuronal (M1), cardiac (M2), and pancreatic (M3) muscarinic receptors.
      M Waelbroeck, M Tastenoy, J Camus and J Christophe
      Molecular Pharmacology September 1991, 40 (3) 413-420;

  2. Wall, S C

    1. Binding of the cocaine analog 2 beta-[3H] carboxymethoxy-3 beta-(4-fluorophenyl)tropane to the serotonin transporter.
      G Rudnick and S C Wall
      Molecular Pharmacology September 1991, 40 (3) 421-426;

  3. Walsh, K B

    1. Activation of a heart chloride current during stimulation of protein kinase C.
      K B Walsh
      Molecular Pharmacology September 1991, 40 (3) 342-346;

  4. Wu, F S

    1. Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-D-aspartate receptor.
      F S Wu, T T Gibbs and D H Farb
      Molecular Pharmacology September 1991, 40 (3) 333-336;

Y

  1. Yamanaka, G

    1. Selective activity and cellular pharmacology of (1R-1 alpha,2 beta,3 alpha)-9-[2,3-bis(hydroxymethyl)cyclobutyl]guanine in herpesvirus-infected cells.
      G Yamanaka, A V Tuomari, M Hagen, B McGeever-Rubin, B Terry, M Haffey, G S Bisacchi and A K Field
      Molecular Pharmacology September 1991, 40 (3) 446-453;

Z

  1. Zeng, D W

    1. Pharmacological characterization of rat alpha 2-adrenergic receptors.
      J K Harrison, D D D'Angelo, D W Zeng and K R Lynch
      Molecular Pharmacology September 1991, 40 (3) 407-412;

  2. Zilberter, Y

    1. Desensitization of N-methyl-D-aspartate receptors in neurons dissociated from adult rat hippocampus.
      Y Zilberter, V Uteshev, S Sokolova and B Khodorov
      Molecular Pharmacology September 1991, 40 (3) 337-341;
Back to top

In this issue